• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性疾病中的心脏磁共振成像:简要综述

Cardiac MRI in infiltrative disorders: a concise review.

作者信息

Penugonda Neelima

机构信息

Department of Internal Medicine, Lankenau Hospital, Wynnewood, PA, USA.

出版信息

Curr Cardiol Rev. 2010 May;6(2):134-6. doi: 10.2174/157340310791162668.

DOI:10.2174/157340310791162668
PMID:21532780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2892079/
Abstract

Cardiac MR imaging is an effective method for noninvasive imaging of the heart. The technology has been limited in the past because of imaging difficulties associated with cardiac motion. In recent years, however, cardiac MR imaging has broadened its spectrum of applications in cardiovascular disease with impressive advances in spatial and temporal resolution and increased imaging speeds. This review presents the current clinical applications of cardiac MR imaging for evaluation of cardiac disease in infiltrative disorders such as amyloidosis, hemochromatosis, and sarcoidosis.

摘要

心脏磁共振成像(Cardiac MR imaging)是一种用于心脏无创成像的有效方法。过去,由于与心脏运动相关的成像困难,这项技术受到了限制。然而,近年来,心脏磁共振成像在空间和时间分辨率以及成像速度方面取得了令人瞩目的进展,其在心血管疾病中的应用范围得到了拓宽。本综述介绍了心脏磁共振成像目前在评估浸润性疾病(如淀粉样变性、血色素沉着症和结节病)中的心脏疾病方面的临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff9/2892079/d8c8ff420553/CCR-6-134_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff9/2892079/e22185f25e3a/CCR-6-134_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff9/2892079/43703595914e/CCR-6-134_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff9/2892079/d8c8ff420553/CCR-6-134_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff9/2892079/e22185f25e3a/CCR-6-134_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff9/2892079/43703595914e/CCR-6-134_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff9/2892079/d8c8ff420553/CCR-6-134_F3.jpg

相似文献

1
Cardiac MRI in infiltrative disorders: a concise review.浸润性疾病中的心脏磁共振成像:简要综述
Curr Cardiol Rev. 2010 May;6(2):134-6. doi: 10.2174/157340310791162668.
2
Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis.浸润性心肌病中的心脏性猝死:结节病、硬皮病、淀粉样变性、血色素沉着症。
Prog Cardiovasc Dis. 2008 Jul-Aug;51(1):58-73. doi: 10.1016/j.pcad.2007.10.003.
3
Two-dimensional and Doppler echocardiographic assessment of infiltrative cardiomyopathy.浸润性心肌病的二维及多普勒超声心动图评估
J Am Soc Echocardiogr. 1988 Jan-Feb;1(1):48-59. doi: 10.1016/s0894-7317(88)80063-4.
4
The Importance of Multimodality Imaging in the Diagnosis and Management of Patients with Infiltrative Cardiomyopathies: An Update.多模态成像在浸润性心肌病患者诊断和管理中的重要性:最新进展
Diagnostics (Basel). 2021 Feb 7;11(2):256. doi: 10.3390/diagnostics11020256.
5
[MRI in cardiac sarcoidosis and amyloidosis].[心脏结节病和淀粉样变性的磁共振成像]
Radiologe. 2013 Jan;53(1):54-60. doi: 10.1007/s00117-012-2386-0.
6
Applications of PET-MR Imaging in Cardiovascular Disorders.正电子发射断层扫描-磁共振成像在心血管疾病中的应用。
PET Clin. 2020 Oct;15(4):509-520. doi: 10.1016/j.cpet.2020.06.007. Epub 2020 Jul 21.
7
Role of Imaging in Evaluating Infiltrative Heart Disease.影像学在评估浸润性心脏病中的作用。
Curr Treat Options Cardiovasc Med. 2017 Jan;19(1):3. doi: 10.1007/s11936-017-0500-3.
8
Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction.射血分数保留的心力衰竭所致浸润性心肌病的临床评估
Rev Cardiovasc Med. 2020 Jun 30;21(2):181-190. doi: 10.31083/j.rcm.2020.02.65.
9
Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series.限制型和浸润型心肌病的分类:系列文章的第 1 部分
J Am Coll Cardiol. 2018 Mar 13;71(10):1130-1148. doi: 10.1016/j.jacc.2018.01.016.
10
A review of systemic infiltrative diseases and associated endocrine diseases.系统性浸润性疾病及相关内分泌疾病综述。
Endocrinol Diabetes Nutr (Engl Ed). 2021 May;68(5):312-320. doi: 10.1016/j.endien.2021.08.006. Epub 2021 Sep 6.

引用本文的文献

1
Cardiac Magnetic Resonance Imaging in the Evaluation and Prognosis of Infiltrative Cardiomyopathies.心脏磁共振成像在浸润性心肌病评估与预后中的应用
J Cardiovasc Dev Dis. 2025 Apr 12;12(4):154. doi: 10.3390/jcdd12040154.
2
Acute Late-Stage Myocarditis in the Crab-Eating Macaque Model of Hemorrhagic Smallpox.出血性天花沙鼠模型中的急性晚期心肌炎。
Viruses. 2021 Aug 9;13(8):1571. doi: 10.3390/v13081571.
3
Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

本文引用的文献

1
Evaluation and management of the cardiac amyloidosis.心脏淀粉样变性的评估与管理
J Am Coll Cardiol. 2007 Nov 27;50(22):2101-10. doi: 10.1016/j.jacc.2007.08.028. Epub 2007 Nov 13.
2
Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects.心脏淀粉样变性:磁共振成像表现及 T1 定量分析,与对照受试者的比较
J Magn Reson Imaging. 2007 Jun;25(6):1283-7. doi: 10.1002/jmri.20917.
3
Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging.利用磁共振成像对心脏结节病进行早期诊断。
多学科方法评估肝移植中心肺血管疾病风险:证据评估和共识推荐。
Am J Transplant. 2018 Jan;18(1):30-42. doi: 10.1111/ajt.14531. Epub 2017 Nov 18.
4
Cardiovascular Magnetic Resonance Imaging-Incremental Value in a Series of 361 Patients Demonstrating Cost Savings and Clinical Benefits: An Outcome-Based Study.心血管磁共振成像——361例患者系列研究中的增量价值,显示出成本节约和临床益处:一项基于结果的研究
Clin Med Insights Cardiol. 2017 May 19;11:1179546817710026. doi: 10.1177/1179546817710026. eCollection 2017.
5
Factoring in the missing link.考虑到缺失的环节。
Am J Hematol. 2017 Jan;92(1):110-113. doi: 10.1002/ajh.24501. Epub 2016 Aug 22.
6
A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir.使用 (18)F-氟脱氧葡萄糖(18)F-Florbetapir 评估心脏淀粉样变性的简化计算常规 PET/CT 方案
Front Cardiovasc Med. 2015 May 8;2:23. doi: 10.3389/fcvm.2015.00023. eCollection 2015.
7
Infiltrative Cardiomyopathies.浸润性心肌病
Clin Med Insights Cardiol. 2015 Jul 8;9(Suppl 2):29-38. doi: 10.4137/CMC.S19706. eCollection 2015.
8
CT and MRI evaluation of cardiac complications in patients with hematologic diseases: a pictorial review.血液系统疾病患者心脏并发症的CT和MRI评估:图谱综述
Int J Cardiovasc Imaging. 2015 Dec;31 Suppl 2:159-67. doi: 10.1007/s10554-015-0610-5. Epub 2015 Feb 5.
9
Cardiac sarcoidosis: case report, workup, and review of the literature.心脏结节病:病例报告、检查及文献综述
Cardiol Ther. 2013 Dec;2(2):181-97. doi: 10.1007/s40119-013-0017-0. Epub 2013 Jun 18.
Int J Cardiol. 2008 Mar 28;125(1):e4-5. doi: 10.1016/j.ijcard.2006.11.224. Epub 2007 Mar 6.
4
Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.系统性淀粉样变性的心脏改变:磁共振成像可视化
Int J Cardiol. 2006 Oct 26;113(1):E21-3. doi: 10.1016/j.ijcard.2006.07.107. Epub 2006 Oct 17.
5
Cardiac amyloidosis: typical imaging findings and diffuse myocardial damage demonstrated by delayed contrast-enhanced MRI.心脏淀粉样变性:延迟对比增强磁共振成像显示的典型影像学表现及弥漫性心肌损伤
Cardiovasc Intervent Radiol. 2006 Jul-Aug;29(4):710-2. doi: 10.1007/s00270-004-0162-x.
6
Evaluation of myocardial iron overload by T2* cardiovascular magnetic resonance imaging.通过T2*心血管磁共振成像评估心肌铁过载。
Tex Heart Inst J. 2005;32(3):448-9.
7
MR imaging of cardiac tumors.心脏肿瘤的磁共振成像
Radiographics. 2005 Sep-Oct;25(5):1255-76. doi: 10.1148/rg.255045721.
8
Early diagnosis of hemochromatosis-related cardiomyopathy with magnetic resonance imaging.利用磁共振成像对血色素沉着症相关性心肌病进行早期诊断。
J Cardiovasc Magn Reson. 2005;7(4):689-92. doi: 10.1081/jcmr-65632.
9
Sarcoid heart disease: clinical course and treatment.结节病性心脏病:临床病程与治疗
Int J Cardiol. 2004 Nov;97(2):173-82. doi: 10.1016/j.ijcard.2003.07.024.
10
Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome.与心脏结节病相关的室性快速性心律失常:其机制与转归
Clin Cardiol. 2004 Apr;27(4):217-22. doi: 10.1002/clc.4960270409.